BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36950490)

  • 1. Recompensation in Cirrhosis: Current Evidence and Future Directions.
    Sharma S; Roy A
    J Clin Exp Hepatol; 2023; 13(2):329-334. PubMed ID: 36950490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosis.
    Hofer BS; Simbrunner B; Hartl L; Jachs M; Balcar L; Paternostro R; Schwabl P; Semmler G; Scheiner B; Trauner M; Mandorfer M; Reiberger T
    Liver Int; 2023 Oct; 43(10):2220-2231. PubMed ID: 37469291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of Complications in Cirrhosis.
    Premkumar M; Anand AC
    J Clin Exp Hepatol; 2022; 12(4):1150-1174. PubMed ID: 35814522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baveno VII criteria for recompensation predict transplant-free survival in patients with hepatitis B-related decompensated cirrhosis.
    Hui VW; Wong GL; Wong VW; Chan HL; Lai JC; Tse YK; Lai MS; Yam TF; Li D; Fan X; Yip TC
    JHEP Rep; 2023 Sep; 5(9):100814. PubMed ID: 37546279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Baveno VII concept of cirrhosis recompensation.
    Reiberger T; Hofer BS
    Dig Liver Dis; 2023 Apr; 55(4):431-441. PubMed ID: 36646527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score.
    Kang SH; Jeong WK; Baik SK; Cha SH; Kim MY
    J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):860-870. PubMed ID: 30371017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.
    Chawla YK; Kashinath RC; Duseja A; Dhiman RK
    J Clin Exp Hepatol; 2011 Dec; 1(3):161-8. PubMed ID: 25755381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
    Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
    JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute-on-Chronic Liver Failure (ACLF) in Coastal Eastern India: "A Single-Center Experience".
    Pati GK; Singh A; Misra B; Misra D; Das HS; Panda C; Singh SP
    J Clin Exp Hepatol; 2016 Mar; 6(1):26-32. PubMed ID: 27194893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recompensation of complications in patients with hepatitis B virus-related decompensated cirrhosis treated with entecavir antiviral therapy].
    Zhang T; Deng Y; Kang HY; Xiang HL; Nan YM; Hu JH; Meng QH; Fang JL; Xu J; Wang XM; Zhao H; Pan CQ; Jia JD; Xu XY; Xie W
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jul; 31(7):692-697. PubMed ID: 37580250
    [No Abstract]   [Full Text] [Related]  

  • 11. Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis.
    Wang Q; Zhao H; Deng Y; Zheng H; Xiang H; Nan Y; Hu J; Meng Q; Xu X; Fang J; Xu J; Wang X; You H; Pan CQ; Xie W; Jia J
    J Hepatol; 2022 Dec; 77(6):1564-1572. PubMed ID: 36038017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease.
    Balcar L; Krawanja J; Scheiner B; Paternostro R; Simbrunner B; Semmler G; Jachs M; Hartl L; Stättermayer AF; Schwabl P; Pinter M; Szekeres T; Trauner M; Reiberger T; Mandorfer M
    JHEP Rep; 2023 Apr; 5(4):100682. PubMed ID: 36873421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.
    Costa D; Simbrunner B; Jachs M; Hartl L; Bauer D; Paternostro R; Schwabl P; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T
    J Hepatol; 2021 Apr; 74(4):819-828. PubMed ID: 33075344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India.
    Shah AS; Amarapurkar DN
    J Clin Exp Hepatol; 2018 Mar; 8(1):50-57. PubMed ID: 29743797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
    Jindal A; Agarwal S; Sharma S; Kumar M; Saraya A; Sarin SK
    Dig Dis Sci; 2023 May; 68(5):2149-2157. PubMed ID: 36562888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impressive recompensation in transjugular intrahepatic portosystemic shunt-treated individuals with complications of decompensated cirrhosis based on Baveno VII criteria.
    Gao L; Li MB; Li JY; Liu Y; Ren C; Feng DP
    World J Gastroenterol; 2023 Oct; 29(38):5383-5394. PubMed ID: 37900585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension.
    Azoulay D; Ramos E; Casellas-Robert M; Salloum C; Lladó L; Nadler R; Busquets J; Caula-Freixa C; Mils K; Lopez-Ben S; Figueras J; Lim C
    JHEP Rep; 2021 Feb; 3(1):100190. PubMed ID: 33294830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.
    Reiniš J; Petrenko O; Simbrunner B; Hofer BS; Schepis F; Scoppettuolo M; Saltini D; Indulti F; Guasconi T; Albillos A; Téllez L; Villanueva C; Brujats A; Garcia-Pagan JC; Perez-Campuzano V; Hernández-Gea V; Rautou PE; Moga L; Vanwolleghem T; Kwanten WJ; Francque S; Trebicka J; Gu W; Ferstl PG; Gluud LL; Bendtsen F; Møller S; Kubicek S; Mandorfer M; Reiberger T
    J Hepatol; 2023 Feb; 78(2):390-400. PubMed ID: 36152767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery in a patient with liver disease.
    Rai R; Nagral S; Nagral A
    J Clin Exp Hepatol; 2012 Sep; 2(3):238-46. PubMed ID: 25755440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of Sofosbuvir Plus Ribavirin in Patients With Hepatitis C Related Decompensated Cirrhosis.
    Tmu N; Kumar A; Sharma P; Singla V; Bansal N; Arora A
    J Clin Exp Hepatol; 2019; 9(1):4-12. PubMed ID: 30765933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.